Physician profile
Eric C Phillips
NPI 1639142391
$883.18
in general payments reported to CMS, 2019-2025
10 companies · $158 in 2025
The $158 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $169 · 2021: $116 · 2022: $27.77 · 2023: $337 · 2024: $76.58 · 2025: $158.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $571.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $571.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $365.31 | 2023-2024 | |
| Pfizer INC. | $180.96 | 2019-2025 | |
| Novo Nordisk INC | $124.89 | 2019-2025 | Ozempic, Wegovy, Rybelsus |
| Exact Sciences Corporation | $63.79 | 2025 | Cologuard Collection Kit |
| Novartis Pharmaceuticals Corporation | $34.53 | 2019 | |
| Sanofi-Aventis U.S. LLC | $30.56 | 2019 | |
| Lilly USA, LLC | $26.95 | 2025 | Zepbound, Mounjaro |
| Merck Sharp & Dohme LLC | $23.04 | 2019-2021 | |
| Circassia INC. | $17.51 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.64 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Phillips listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.